24/7 Market News Snapshot 31 October, 2024 – EVOGENE LTD. (NASDAQ:EVGN)

October 31, 2024

DENVER, Colo., 31 October, 2024 (247marketnews.com) – (NASDAQ:EVGN) are discussed in this article.
Evogene Ltd. (EVGN) is witnessing a remarkable surge in market activity, currently trading at $3.635, representing a significant increase of 51.46% from its previous closing price of $2.400. This uptick is accompanied by a robust trading volume of 1.19 million shares, indicative of strong investor interest and market confidence. This momentum is likely fueled by recent strategic developments within the company that merit close monitoring.

Notably, Evogene has entered a transformative collaboration with Google Cloud, which aims to revolutionize the design and development of small molecules in the life sciences domain. This partnership will leverage Evogene’s innovative ChemPass AI technology in conjunction with Google Cloud’s powerful computational resources to create a state-of-the-art AI foundation model dedicated to generative small molecule design.

Through this collaboration, Evogene plans to harness Google Cloud’s Vertex AI, along with cutting-edge GPUs and extensive storage capabilities, to train its new model on a dataset of approximately 40 billion molecular structures. This advanced model is expected to significantly accelerate the identification and evaluation of novel small molecules applicable to drug development, sustainable agriculture, and various life science products, enhancing both the speed and accuracy of candidate generation.

Ofer Haviv, President and CEO of Evogene, articulated the importance of this partnership, stating, “Our collaboration with Google Cloud underscores our commitment to advancing innovation in computational predictive biology.” The anticipated breakthroughs from this initiative promise substantial benefits not only to Evogene but also to stakeholders within the pharmaceutical and agricultural sectors.

By synergizing Evogene’s expertise in computational biology with Google Cloud’s leading-edge AI tools, this partnership is set to reshape research and development efforts, aiding organizations in achieving a competitive advantage through advanced generative design capabilities. The industry is poised for groundbreaking advancements, positioning Evogene and Google Cloud at the forefront of innovation in life sciences.

Related news for (EVGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.